BULLA, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 164
EU - Europa 148
AS - Asia 138
AF - Africa 32
SA - Sud America 17
Totale 499
Nazione #
US - Stati Uniti d'America 160
IT - Italia 66
SG - Singapore 59
RU - Federazione Russa 53
CN - Cina 52
CI - Costa d'Avorio 20
BR - Brasile 16
KR - Corea 13
IE - Irlanda 9
FI - Finlandia 5
IN - India 5
PL - Polonia 5
SN - Senegal 5
VN - Vietnam 4
BE - Belgio 3
BJ - Benin 3
MX - Messico 3
GB - Regno Unito 2
LT - Lituania 2
NG - Nigeria 2
ZA - Sudafrica 2
AR - Argentina 1
CA - Canada 1
CZ - Repubblica Ceca 1
DE - Germania 1
HK - Hong Kong 1
IL - Israele 1
IQ - Iraq 1
LK - Sri Lanka 1
SE - Svezia 1
TR - Turchia 1
Totale 499
Città #
Singapore 40
Moscow 34
Santa Clara 29
Dallas 28
Hefei 28
Abidjan 20
Catania 20
Ashburn 18
Seoul 13
Chicago 11
Los Angeles 10
Dublin 9
Civitanova Marche 8
Palermo 6
Beijing 5
Boardman 5
Dakar 5
Warsaw 5
Bari 3
Brussels 3
Cotonou 3
Lappeenranta 3
Mexico City 3
Pozzallo 3
Abuja 2
Acireale 2
Bologna 2
Bronte 2
Buffalo 2
Caselle Torinese 2
Florence 2
Helsinki 2
Johannesburg 2
Messina 2
Milan 2
New York 2
Redondo Beach 2
Ribeirão Preto 2
São Paulo 2
Ankara 1
Augusta 1
Belo Horizonte 1
Boa Vista 1
Boston 1
Brno 1
Brooklyn 1
Bắc Ninh 1
Cambridge 1
Catanduva 1
Chandler 1
City of London 1
Colombo 1
Concórdia 1
Cosenza 1
Criciúma 1
Curitiba 1
Destin 1
Galesburg 1
Grand Rapids 1
Guarujá 1
Hanoi 1
Hong Kong 1
Houston 1
Jerusalem 1
Kingsville 1
Lawrence 1
Lexington 1
Lu'an 1
Lấp Vò 1
Mascalucia 1
Misterbianco 1
Montreal 1
Mumbai 1
Munich 1
Najaf 1
New Delhi 1
Orzivecchi 1
Paternò 1
Phoenix 1
Pirenópolis 1
Quảng Ngãi 1
Rome 1
Sacramento 1
San Francisco 1
Santos 1
Seattle 1
Siliguri 1
Stockholm 1
Suzano 1
São João de Meriti 1
São Lourenço 1
Villa Dolores 1
Washington 1
Āzādpur 1
Totale 397
Nome #
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 131
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 102
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 99
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 98
Reduced Absolute Count of Monocytes in Patients Carrying Hematological Neoplasms and SARS-CoV2 Infection 74
Totale 504
Categoria #
all - tutte 1.758
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.758


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20223 0 0 0 0 0 0 0 0 0 1 0 2
2022/202338 2 0 1 0 3 3 1 7 4 0 12 5
2023/202454 3 13 4 3 3 11 3 3 0 1 7 3
2024/2025149 2 18 5 12 23 14 2 11 7 12 21 22
2025/2026260 30 49 37 33 53 58 0 0 0 0 0 0
Totale 504